FindTrial
Sign In

Economic burden of COVID on Kidney related disorders

Economic implications of acute kidney injury in critically ill patients with COVID-19.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/03/040843
Enrollment
260
Registered
2022-03-04
Start date
Unknown
Completion date
Unknown
Last updated
2022-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N179- Acute kidney failure, unspecified Health Condition 2: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

None listed

Sponsors

Kasturba Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All patient admissions to COVID-19 ICU with and without AKI. Patient with stage 1, stage 2, stage 3 of AKI classification by KDIGO criteria.

Exclusion criteria

Exclusion criteria: All patients who have been partially treated in other ICUs elsewhere for the condition.

Design outcomes

Primary

MeasureTime frame
It analyses the cost burden in COVID-19 patients with acute kidney injury and critical illness and also to compare the hospitalization expense between AKI and non AKITimepoint: 4 months—

Secondary

MeasureTime frame
helps to frame insurance policy and health policy towards patients with kidney diseaseTimepoint: 4 months—

Countries

India

Contacts

Public ContactDr Somu G

Kasturba Medical College, MAHE, Manipal

shenoy.srinivas@manipal.edu9844374705

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026